12 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... Active malignancy ... Management #VTE #DVT ... #Algorithm #Venous ... Thromboembolism #Treatment #Hematology
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... for First Time DVT ... Unprovoked • Active Malignancy ... #hematology #VTE ... #thrombosis #venous
Causes of Diffuse and Localized Lymphadenopathy - Differential Diagnosis Algorithm
 • Reactive (Inflammatory / Infectious)
 •
of Diffuse and Localized ... - Differential Diagnosis ... Algorithm • Reactive ... #Algorithm #Causes ... #Hematology #Oncology
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
Causes of Localized ... - Differential Diagnosis ... Algorithm Cervical ... #Algorithm #Causes ... #Hematology #Oncology
Causes of Arterial and Venous Thrombosis - Differential Diagnosis Framework

STRUCTURAL:
 - PFO: paradoxical emboli
 - Popliteal
- Differential Diagnosis ... compression and DVT ... MALIGNANCY: ... #Differential #Diagnosis ... #clots #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
DVT = deep vein ... mass index; VTE = venous ... #DOAC #VTE #Malignancy ... Anticoagulation #Management #Hematology ... #Oncology
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
history of prior venous ... trauma, active malignancy ... Hypercoagulable #Workup #hematology ... #diagnosis #algorithm ... #hematology #VTE
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... and incidental DVT ... without concomitant DVT ... Anticoagulation #Management #Hematology ... #Oncology
Hodgkin's Lymphoma vs Non-Hodgkin's Lymphoma - Comparison

Hodgkin's Lymphoma:
 • Epidemiology: young adults 20-30, older 50-70
 •
older 50-70 • Malignant ... Adenopathy (painless)-localized ... Differential Diagnosis ... NonHodgkins #comparison #oncology ... #hematology
Paraproteinemias

Entities That Can Feature A Monoclonal Protein/M Component:
• MM
• WM
• MGUS
• MGCS
• MGRS
• Splenic Marginal Zone
Entities That Can Feature ... beds-renal, retinal, DVT ... Paraproteinemias #Hematology ... #Differential #Diagnosis ... #Oncology